Skip to main content
. 2018 Jan 23;118(5):662–669. doi: 10.1038/bjc.2017.479

Figure 1.

Figure 1

Correlation of KRAS mutations in cfDNA from postoperative serum with postoperative survival of PDAC patients. KRAS mutations in postoperative cell free DNA (cfDNA) significantly correlated with disease-free survival (A) and overall survival (B).